On ECHEMI
Home > Drugs > Bone hyperplasia
Bone hyperplasia
Osteoarthritis, also known as hyperplastic osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, and hypertrophic arthritis, is a disease caused by the degeneration and degradation of soft tissues such as cartilage, intervertebral discs, and ligaments that constitute the joints, the formation of bone spurs at the edges of the joints, and the thickening of the synovium, which leads to bone destruction, secondary bone hyperplasia, and joint deformation. When subjected to abnormal loads, it causes joint pain, limited mobility, and other symptoms. There are two types: primary and secondary.
  • Site of disease:

    bone
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    Bone spurs on knees joint swelling and pain bone spurs on heels bone thickening neck and back pain
Related Drugs
Ginseng oral liquid
Manufacturer:

Jiangxi Kang'enbei Tianshikang Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Jilin Wutai Gankang Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Jilin Jinbao Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Tongyao Pharmaceutical Group Stock Co., Ltd.

Ginseng oral liquid
Manufacturer:

Sichuan Sanxingdui Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Liaoyuan Yulongyadong Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Liaoyuan Yulongyadong Pharmaceutical Co., Ltd.

Ginseng oral liquid
Manufacturer:

Jilin Luobang Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.